v3.25.4
Patent and Technology License Agreements (Details) - USD ($)
3 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 15, 2025
Jul. 15, 2025
Patent and Technology License Agreements [Line Items]        
Fair value of research and development acquired $ 40,000,000      
Development milestone payments 70,000,000      
Commercial sales milestones $ 300,000,000      
Net sales percentage 50.00%      
Outstanding remaining balance of milestone $ 18,250,000      
Reimburse amount 2,650,000      
Aggregate amount of milestone payments       $ 2,535,318
Final payment     $ 2,197,892  
Interest rate per annum     2.00%  
Interest expense 45,841    
Accounts payable 2,700,000      
Accrued expenses 4,062,481      
License Agreement [Member]        
Patent and Technology License Agreements [Line Items]        
Payment for Milestone 5,900,000      
Dr. Reddy’s [Member]        
Patent and Technology License Agreements [Line Items]        
Development milestone payments 40,000,000      
Dr. Reddy’s [Member] | Asset Purchase Agreement [Member]        
Patent and Technology License Agreements [Line Items]        
Payment for Milestone 27,500,000      
Licensing Agreements [Member]        
Patent and Technology License Agreements [Line Items]        
Outstanding remaining balance of milestone 22,000,000      
Licensing Agreements [Member] | Eisai [Member]        
Patent and Technology License Agreements [Line Items]        
Aggregate amount of milestone payments       $ 2,350,000
Extension fee payable $ 10,000,000      
Minimum [Member]        
Patent and Technology License Agreements [Line Items]        
Percentage of royalty on net product sales 10.00%      
Maximum [Member]        
Patent and Technology License Agreements [Line Items]        
Percentage of royalty on net product sales 15.00%